Evidence map›Paper›PMID 38098938›Full record

ArticleFrontiers in molecular neuroscience2023

Characterization of a phenotypically severe animal model for human AB-Variant GM2 gangliosidosis.

Natalie M Deschenes, Camilyn Cheng, Prem Khanal, Brianna M Quinville, Alex E Ryckman, Melissa Mitchell, Alexey V Pshezhetsky, Jagdeep S Walia

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Degradation System: Sialidase.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Natalie M DeschenesCentre for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
Camilyn ChengCentre for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
Prem KhanalDepartment of Pediatrics, Queen's University, Kingston, ON, Canada.
Brianna M QuinvilleCentre for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
Alex E RyckmanCentre for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
Melissa MitchellDepartment of Pediatrics, Queen's University, Kingston, ON, Canada.
Alexey V PshezhetskyCentre Hospitalier Universitaire Sainte-Justine Research Centre, Department of Pediatrics, University of Montreal, Montreal, QC, Canada.
Jagdeep S WaliaCentre for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
Queen's University · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AB-Variant GM2 gangliosidosis (ABGM2) is a rare and lethal genetic disorder caused by mutations in the

Indexed as

ABGM2 gangliosidosiscentral nervous systemGM2 activator proteinmouse modelNEU3

Identifiers

PMID38098938
PMCPMC10720325
OpenAlexW4389200714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.